Authors:Christopher S. Eickhoff, Saint Louis UniversityKrystal A. Meza, Saint Louis UniversityFrances E. Terry, EpiVax IncorporatedChase G. Colbert, Saint Louis UniversityAzra Blazevic, Saint Louis UniversityAndres H. Gutiérrez, EpiVax IncorporatedE. Taylor Stone, Saint Louis UniversityJames D. Brien, Saint Louis UniversityAmelia K. Pinto, Saint Louis UniversityHana M. El Sahly, Baylor College of MedicineMark Mulligan, Emory UniversityNadine Rouphael, Emory UniversityMaria L. Alcaide, University of MiamiKay M. Tomashek, National Institute of Allergy and Infectious Diseases (NIAID)Chris Focht, The Emmes Company, LLCWilliam D. Martin, EpiVax IncorporatedLeonard Moise, EpiVax IncorporatedAnne S. De Groot, EpiVax IncorporatedDaniel F. Hoft, Saint Louis University
Authors:Jay Overholser, The Ohio State University Wexner Medical CenterKristen Henkins Ambegaokar, The Ohio State University Wexner Medical CenterSiobhan M. Eze, Emory UniversityEduardo Sanabria-Figueroa, Emory UniversityRita Nahta, Emory UniversityTanios Bekaii-Saab, The Ohio State UniversityPravin T.P. Kaumaya, The Ohio State University Wexner Medical Center